IGF-1 DES vs Palmitoyl Dipeptide-6
Side-by-side comparison of key properties, dosing, and research.
Anabolic & IGF
IGF-1 DESSkin & CosmeticAnti-Aging & Longevity
Palmitoyl Dipeptide-6- Summary
- IGF-1 DES (also written DES(1-3)IGF-1) is a truncated form of IGF-1 missing the first three amino acids of the N-terminus. This structural change dramatically reduces its affinity for IGF binding proteins (IGFBPs), meaning a far greater fraction remains in its free, active form. IGF-1 DES is estimated to be 10x more potent than standard IGF-1 LR3 at the receptor level locally, making it particularly effective for site-specific muscle growth when injected intramuscularly.
- Palmitoyl Dipeptide-6 is a synthetic dipeptide (lysine-threonine) with a palmitoyl fatty acid tail, designed to penetrate the skin barrier and stimulate the extracellular matrix components essential for skin firmness. It activates fibronectin and type IV collagen synthesis, improving skin density and firmness particularly in mature or sagging skin.
- Half-Life
- ~20–30 minutes (very short — designed for local action)
- Not applicable (topical)
- Admin Route
- IM, SubQ
- Topical
- Research
- —
- —
- Typical Dose
- 20–50 mcg per injection site
- 0.005–0.05% in formulation
- Frequency
- Once daily, post-workout
- Once or twice daily
- Key Benefits
- Estimated 10x greater potency at the receptor vs IGF-1 LR3 locally
- Minimal IGFBP binding — nearly all active upon injection
- Highly localized muscle growth effect when injected intramuscularly
- Activates satellite cells for muscle fiber hyperplasia potential
- Synergistic with GH peptides in post-workout anabolic protocols
- Shorter half-life reduces systemic exposure vs IGF-1 LR3
- Useful for site-specific muscle development
- Increases skin firmness and density
- Stimulates fibronectin and collagen IV production
- Strengthens the dermal-epidermal junction
- Reduces skin sagging in mature skin
- Improves skin texture and smoothness
- Supports extracellular matrix integrity
- Side Effects
- Hypoglycemia (most significant risk — especially post-workout)
- Localized muscle swelling at injection site
- Potential for jaw/organ growth (acromegalic effects) with prolonged high-dose use
- Carpal tunnel syndrome with high doses
- +1 more
- Generally well-tolerated
- Rare mild skin irritation in sensitive individuals
- No known systemic effects at cosmetic concentrations
- Stacks With
- —
- —